abstract |
Selective MMP-13 inhibitors are benzo thiadiazines of the Formulaor a pharmaceutically acceptable salt thereof, wherein R<2 >is hydrogen or alkyl; R<1 >and R<3 >include hydrogen, alkyl, and aryl, with the proviso that R<3 >is not (CH2)m biphenyl or (CH2)m substituted biphenyl; X is O or NH, n is 0, 1, or 2. The compounds of Formula I, or a pharmaceutically acceptable salt thereof, is useful for treating diseases mediated by an MMP-13 enzyme, including diseases selected from osteoarthritis, rheumatoid arthritis, cancer, inflammation, and heart failure. |